Retinal Vascular Occlusion and Underlying Generalized Vascular Diseases

Abstract

Retinal vascular occlusion not only threatens vision loss but is also associated with other systemic risk factors and vascular diseases. Interdisciplinary cooperation is of great importance in these patients. The risk factors hardly differ between arterial and venous retinal occlusions, which is due to the special anatomy of retinal vessels. Major underlying conditions associated with retinal vascular occlusion include arterial hypertension, diabetes mellitus, dyslipidemia, cardiac disease, particularly atrial fibrillation, or vasculitis of large- and middle-sized arteries. Every new diagnosed retinal vascular occlusion should therefore be taken as an occasion to search for risk factors and possibly adjust an already existing therapy in order to prevent further vascular events.

Key words

retina - vascular occlusion - risk factors - embolism

Publication History

Received: 05 May 2023

Accepted: 19 May 2023

Accepted Manuscript online:
22 May 2023

Article published online:
31 July 2023

• References/Literatur

• 1 Lavin P, Patrylo M, Hollar M. et al. Stroke Risk and Risk Factors in Patients With Central Retinal Artery Occlusion. Am J Ophthalmol 2018; 196: 96-100
• 2 Biousse V, Nahab F, Newman NJ. Management of Acute Retinal Ischemia: Follow the Guidelines!. Ophthalmology 2018; 125: 1597-1607
• 3 Flaxel CJ, Adelman RA, Bailey ST. et al. Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern^® . Ophthalmology 2020; 127: P259-P287
• 4 Scott IU, Campochiaro PA, Newman NJ. et al. Retinal vascular occlusions. Lancet 2020; 396: 1927-1940
• 5 Lang GE, Lang SJ. [Retinal Artery Occlusions]. Klin Monbl Augenheilkd 2018; 235: 109-120
• 6 Etminan M, Sodhi M, Mikelberg FS. et al. Risk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US. JAMA Ophthalmol 2022; 140: 480-484
• 7 Li AS, Pomeranz HD. Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use. J Neuroophthalmol 2016; 36: 480-481
• 8 Hayreh SS, Podhajsky PA, Zimmerman MB. Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology 2009; 116: 1928-1936
• 9 Callizo J, Feltgen N, Ammermann A. et al. Atrial fibrillation in retinal vascular occlusion disease and non-arteritic anterior ischemic optic neuropathy. PLoS One 2017; 12: e0181766
• 10 Callizo J, Feltgen N, Pantenburg S. et al. Cardiovascular Risk Factors in Central Retinal Artery Occlusion: Results of a Prospective and Standardized Medical Examination. Ophthalmology 2015; 122: 1881-1888
• 11 Yen JC, Lin HL, Hsu CA. et al. Atrial Fibrillation and Coronary Artery Disease as Risk Factors of Retinal Artery Occlusion: A Nationwide Population-Based Study. Biomed Res Int 2015; 2015: 374616
• 12 Wachter R, Weber-Krüger M, Seegers J. et al. Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study. J Neurol 2013; 260: 2042-2045
• 13 Lusk JB, Song A, Unnithan S. et al. Association Between Hospital-Documented Atrial Fibrillation and Central Retinal Artery Occlusion. Stroke 2023; 54: 983-991
• 14 Mir TA, Arham AZ, Fang W. et al. Acute Vascular Ischemic Events in Patients With Central Retinal Artery Occlusion in the United States: A Nationwide Study 2003–2014. Am J Ophthalmol 2019; 200: 179-186
• 15 Scoles D, McGeehan B, VanderBeek BL. The association of stroke with central and branch retinal arterial occlusion. Eye (Lond) 2022; 36: 835-843
• 16 Schorr EM, Rossi KC, Stein LK. et al. Characteristics and Outcomes of Retinal Artery Occlusion: Nationally Representative Data. Stroke 2020; 51: 800-807
• 17 Park SJ, Choi NK, Yang BR. et al. Risk and Risk Periods for Stroke and Acute Myocardial Infarction in Patients with Central Retinal Artery Occlusion. Ophthalmology 2015; 122: 2336-2343.e2
• 18 Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e.V. (RG), Berufsverband der Augenärzte Deutschlands e.V. (BVA). [Retinal arterial occlusions (RAV): S2e guidelines of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Association of Ophthalmologists (BVA). Version: 7 October 2022]. Ophthalmologie 2023; 120 (Suppl. 01) S15-S20
• 19 González-Gay MA, Blanco R, Rodríguez-Valverde V. et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 1998; 41: 1497-1504
• 20 Neß T, Schmidt W. [Eye involvement in large vessel vasculitis (giant cell arteritis and Takayasuʼs arteritis)]. Ophthalmologe 2019; 116: 899-914
• 21 Kermani TA, Schmidt J, Crowson CS. et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 2012; 41: 866-871
• 22 Hayreh SS. Acute retinal arterial occlusive disorders. Prog Retin Eye Res 2011; 30: 359-394
• 23 Schmidt D, Hetzel A, Geibel-Zehender A. et al. Systemic diseases in non-inflammatory branch and central retinal artery occlusion–an overview of 416 patients. Eur J Med Res 2007; 12: 595-603
• 24 Stepanov A, Hejsek L, Jiraskova N. et al. Transient branch retinal artery occlusion in a 15-year-old girl and review of the literature. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015; 159: 508-511
• 25 [Anonym] Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands zur Therapie des Makulaödems beim retinalen Venenverschluss. Ophthalmologe 2010; 107: 583-596
• 26 Feltgen N, Pielen A. Retinaler Arterienverschluss. Ophthalmologe 2017; 114: 177-190
• 27 Seitz R. Die Netzhautgefäße. Stuttgart: Ferdinand Enke; 1962
• 28 Feltgen N. Arteriovenous Dissection in a Living Human Eye: Clinicopathologic Correlation. Arch Ophthalmol 2005; 123: 571
• 29 Martin G, Wefelmeyer KL, Bucher F. et al. Arteriovenous crossing in retinal vessels of mice, rats, and pigs. Mol Vis 2020; 26: 731-741
• 30 Ørskov M, Vorum H, Larsen TB. et al. Similarities and differences in systemic risk factors for retinal artery occlusion and retinal vein occlusion: A nationwide case-control study. Int Ophthalmol 2023; 43: 817-824
• 31 Frederiksen KH, Stokholm L, Frederiksen PH. et al. Cardiovascular morbidity and all-cause mortality in patients with retinal vein occlusion: a Danish nationwide cohort study. Br J Ophthalmol 2022;
• 32 Bertelsen M, Linneberg A, Christoffersen N. et al. Mortality in Patients with Central Retinal Vein Occlusion. Ophthalmology 2014; 121: 637-642
• 33 Bakhoum CY, Madala S, Long CK. et al. Retinal vein occlusion is associated with stroke independent of underlying cardiovascular disease. Eye (Lond) 2023; 37: 764-767
• 34 Werther W, Chu L, Holekamp N. et al. Myocardial infarction and cerebrovascular accident in patients with retinal vein occlusion. Arch Ophthalmol 2011; 129: 326-331
• 35 Chen YY, Sheu SJ, Hu HY. et al. Association between retinal vein occlusion and an increased risk of acute myocardial infarction: A nationwide population-based follow-up study. PLoS One 2017; 12: e0184016
• 36 Lim DH, Shin KY, Han K. et al. Differential Effect of the Metabolic Syndrome on the Incidence of Retinal Vein Occlusion in the Korean Population: A Nationwide Cohort Study. Transl Vis Sci Technol 2020; 9: 15
• 37 Li M, Hu X, Huang J. et al. Impact of Retinal Vein Occlusion on Stroke Incidence: A Meta-Analysis. J Am Heart Assoc 2016; 5: e004703
• 38 Plunkett O, Lip PL, Lip GYH. Atrial fibrillation and retinal vein or artery occlusion: looking beyond the eye. Br J Ophthalmol 2014; 98: 1141-1143
• 39 Wu CY, Riangwiwat T, Limpruttidham N. et al. Association of Retinal Vein Occlusion with Cardiovascular Events and Mortality: A Systematic Review and Meta-analysis. Retina 2019; 39: 1635-1645
• 40 Trovato Battagliola E, Pacella F, Malvasi M. et al. Risk factors in central retinal vein occlusion: A multi-center case-control study conducted on the Italian population: Demographic, environmental, systemic, and ocular factors that increase the risk for major thrombotic events in the retinal venous system. Eur J Ophthalmol 2022; 32: 2801-2809
• 41 Höhn R, Kottler U, Peto T. et al. The ophthalmic branch of the Gutenberg Health Study: study design, cohort profile and self-reported diseases. PLoS One 2015; 10: e0120476
• 42 Ponto KA, Elbaz H, Peto T. et al. Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study. J Thromb Haemost 2015; 13: 1254-1263
• 43 Ponto KA, Scharrer I, Binder H. et al. Hypertension and multiple cardiovascular risk factors increase the risk for retinal vein occlusions: results from the Gutenberg Retinal Vein Occlusion Study. J Hypertens 2019; 37: 1372-1383
• 44 Hansen LL. Central retinal Vein Occlusion. In: Joussen A, Gardner T, Kirchhof B, Ryan SJ. eds. Retinal Vascular Disease. Berlin: Springer; 2007: 443-466
• 45 Feltgen N, Pielen A. Retinaler Venenverschluss: Epidemiologie, Einteilung und klinische Befunde. Ophthalmologe 2015; 112: 607-620
• 46 Lang GE, Lang SJ. [Diagnosis and therapy of retinal vein occlusions]. Klin Monbl Augenheilkd 2010; 227: R141-R154
• 47 Lang GE, Spraul CW. [Risk factors for retinal occlusive diseases]. Klin Monbl Augenheilkd 1997; 211: 217-226
• 48 Lang GE, Lang SJ. [Retinal Vein Occlusions]. Klin Monbl Augenheilkd 2018; 235: 1297-1315
• 49 Qin Z, Li X, Ren H. et al. The Correlation between Obstructive Sleep Apnea and Retinal Vein Obstruction: A Meta-Analysis and Systematic Review. Contrast Media Mol Imaging 2022; 2022: 8065629
• 50 Lee CS, Lee ML, Gibbons LE. et al. Associations Between Retinal Artery/Vein Occlusions and Risk of Vascular Dementia. J Alzheimers Dis 2021; 81: 245-253
• 51 Nam GE, Han K, Park SH. et al. Retinal Vein Occlusion and the Risk of Dementia: A Nationwide Cohort Study. Am J Ophthalmol 2021; 221: 181-189
• 52 Lee KS, Nam KH, Kim DW. et al. Risk of Retinal Vein Occlusion in Patients With End-Stage Renal Disease: A 12-Year, Retrospective, Nationwide Cohort Study in South Korea. Invest Ophthalmol Vis Sci 2018; 59: 39-44
• 53 Kuhli-Hattenbach C, Scharrer I, Lüchtenberg M. et al. [Selective thrombophilia screening of young patients with retinal vein occlusion]. Klin Monbl Augenheilkd 2009; 226: 768-773
• 54 Schmidt D, Kramer-Zucker A. [Hemicentral retinal artery occlusion due to oral contraceptives]. Klin Monbl Augenheilkd 2011; 228: 729-733
• 55 Hwang S, Kang SW, Choi KJ. et al. Early menopause is associated with increased risk of retinal vascular occlusions: a nationwide cohort study. Sci Rep 2022; 12: 6068